新型补体B因子小分子抑制剂的设计、合成及生物活性评价OA
Design,synthesis and bioactivity evaluation of novel small-molecule complement factor B inhibitors
目的 针对补体B因子(CFB)疏水结合口袋利用不足、现有抑制剂中吲哚环修饰欠缺导致药效受限的关键问题,开展新型CFB小分子抑制剂设计、合成与活性评价研究,旨在发现高活性CFB抑制剂并验证结构优化策略的科学性.方法 以上市CFB抑制剂LNP023为先导物,基于薛定谔分子模拟平台解析其与CFB共晶结构(PDB:6RAV)的对接模式及结合特征;针对CFB疏水结合口袋未充分利用、吲哚环结构影响配体-靶标结合特异性与亲和力的科学假设,在LNP023吲哚环位点定向引入甲基环丙基等疏水性片段的结构优化设计;对目标化合物开展全合成,并通过核磁共振波谱(NMR)和电喷雾电离质谱(ESI-MS)确证结构,采用ELISA法完成体外CFB抑制活性筛选与评价.结果 共设计、合成了14个未见文献报道的新化合物,结构均经波谱学验证;体外活性结果显示,化合物IB5和 IB6在 50 nmol/L浓度下对 CFB的抑制率分别为 44.9%和 45.4%;其半数抑制浓度(IC50)分别为 53.5和64.5 nmol/L.结论 基于CFB蛋白疏水结合口袋特征的吲哚环定向修饰策略,可显著增强抑制剂与靶标的结合作用,成功获得高活性化合物IB5、IB6,验证了此研究的设计假设,为后续CFB抑制剂的构效关系研究及结构优化提供了关键的先导基础和实验支撑,为补体介导疾病治疗药物的研发提供了新思路.
Objective To design and synthesize highly active complement factor B(CFB)inhibitors and verify the validity of strategies for structural optimization amid insufficient utilization of the hydrophobic binding pocket of CFB and the limited efficacy of existing inhibitors.Methods The marketed CFB inhibitor LNP023 was used as the lead compound,and its docking mode and binding to the co-crystal structure(PDB:6RAV)of CFB were analyzed based on the Schrödinger molecular simulation platform.Given the insufficient utilization of the hydrophobic binding pocket of CFB and the impact of the indole ring structure on the ligand-target binding specificity and affinity,structural optimization was performed by directionally introducing such hydrophobic fragments as methylcyclopropyl around the indole ring of LNP023.Total synthesis of the target compounds was conducted before their structures were confirmed via nuclear magnetic resonance(NMR)spectroscopy and electrospray ionization mass spectrometry(ESI-MS)while thein vitroinhibitory activity of CFB was screened and evaluated via enzyme-linked immunosorbent assay(ELISA).Results A total of 14 new compounds that had not been reported in literature were designed and synthesized,and their structures were all verified by spectroscopy.Analysis of in vitro activity suggested that the inhibition rates of compounds IB5 and IB6 on CFB at a concentration of 50 nmol/L were 44.9%and 45.4%,respectively while their half-maximal inhibitory concentrations(IC50)were 53.5 nmol/L and 64.5 nmol/L,respectively.Conclusion Based on the property of the hydrophobic binding pocket of CFB protein,the strategy for directional modification of the indole ring can significantly enhance the binding effect between the inhibitor and the target so that highly active compounds IB5 and IB6 can be obtained,which verifies the hypothesis about the design of this study.The findings of this study are expected to facilitate subsequent research on structure-activity relationships and structural optimization of CFB inhibitors.
赵志远;张紫云;孙士洋;郑志兵;钟武
军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850
医药卫生
补体B因子分子对接抑制剂结构优化构效关系
complement factor Bmolecular dockinginhibitorstructure optimizationstructure-activity relationship
《军事医学》 2026 (7)
524-534,11
评论